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and!the!presence!of!two!hypervariable!regions,!one!surrounding!the!major!neutralizing!epitope!(10U15).!An!in!vitro!study!found!selection!of!certain!ORF5!genotypes!during!passage!of!virus!in!the!presence!of!PRRSV!antisera,!resulting!in!virus!resistant!to!the!antisera!(16).!In!contrast,!several!studies!of!PRRSV!evolution!in!vivo!have!found!little!evidence!of!immune!selection!using!both!statistical!and!immunological!approaches!(17U19),!reviewed!in!(6,19).!A!more!recent!study!of!viral!genotypes!in!immunocompetent!and!immunodeficient!pigs!(20)!revealed!a!similar!low!rate!of!variation!at!11!and!21!days!postUinfection!(dpi),!and!found!no!evidence!of!immune!selection.!Due!to!the!delayed!adaptive!immune!response!to!PRRSV,!however,!21dpi!may!have!been!too!early!to!detect!selective!pressure!from!the!immune!response.!!The!neutralizing!epitopes!of!PRRSV!are!not!well!characterized,!but!are!most!likely!found!in!the!major!and/or!minor!viral!envelope!proteins,!encoded!by!ORF2U6!(21,22).!ORF5!and!ORF6!encode!the major envelope proteins GP5 and M, respectively, which interact to 
form a heterodimer on the virion surface that is believed to be important for attachment (23-26). 
ORF2-4 encodes the minor envelope proteins, GP2, GP3, and GP4, respectively, which form a 
heterotrimer that interacts with the CD163 receptor (27-31). In addition, nested within ORF2 and 
ORF5 are ORF2a and ORF5a, which encode the E and the 5a proteins, respectively (32,33). 
Both of these proteins are minor components of the virion, and there is some evidence that E 
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ORF2-6 nsp2 









Inoculum N/A 0 25 99.71 24 99.63 
1134 Prolonged 7 8 99.76 10 99.69 28 21 99.63 37 99.50 
3161 Prolonged 7 9 99.71 7 99.81 28 28 99.72 25 99.56 
1113 Rebound 7 9 99.71 7 99.74 35 26 99.62 25 99.54 
3068 Rebound 7 9 99.40 8 99.73 35 31 99.78 32 99.79 
3197 Rebound 7 10 99.49 8 99.69 41 26 99.76 33 99.71 






changes&in!ORF2Z6&and&nsp2a!aSignificant!SNV!were!identified!in!the!CMH!test,!as!described!in!Materials!and!Methods!bFor!ORF2U6,!the!envelope!protein(s)!in!which!the!mutation!occurred!!cAssociated!amino!acid!change.!Blank!entries!represent!synonymous!changes!dSignificance!of!the!change!in!SNV!frequency!over!time!! Gene!Region! Nucleotidea! Locationb! Amino!Acidc! Holm!adj.!PUvalued!RF1! RF2! RF1! RF2!
ORF2U6!
A! 20! G! GP2! E! K7R! !! 2.6!×!10U4!A! 30! G! GP2! E! !! N9D! 5.7!×!10U8!C! 134! T! GP2! E! A45V! !! 3.9!×!10U3!A! 159! T! GP2! E! E53D! M52L! 4.7!×!10U10!A! 291! G! GP2! !! I97M! !! 5.2!×!10U4!A! 711! G! GP2! GP3! I237M! T30A! 2.0!×!10U4!T! 909! C! GP3! !! S96P! !! 8.2!×!10U5!C! 1050! T! GP3! !! L143F! !! 1.2!×!10U13!C! 1510! T! GP4! !! !! !! 7.9!×!10U3!G! 1523! A! GP4! !! G119S! !! 6.2!×!10U5!G! 1538! A! GP4! !! V124I! !! 5.1!×!10U7!A! 1553! G! GP4! !! I129V! !! 1.2!×!10U19!C! 1795! T! GP5! !! A27V! !! 1.3!×!10U7!A! 1810! G! GP5! Orf5a! N32S! K35Q! 3.7!×!10U3!G! 1838! A! GP5! Orf5a! !! !! 3.8!×!10U6!A! 1884! G! GP5! !! K57E! !! 3.8!×!10U6!A! 1958! T! GP5! !! !! !! 7.9!×!10U3!G! 2489! T! M! !! V63L! !! 3.8!×!10U6!
nsp2!






A! 1911! G! !! !! !! !! 1.1!×!10U8!C! 1992! T! !! !! !! !! 7.4!×!10U3!A! 2121! G! !! !! !! !! 1.0!×!10U3!T! 2359! C! !! !! S787P! 9.3!×!10U13!C! 2587! T! !! !! H863Y! 8.3!×!10U5!G! 2664! A! !! !! !! !! 5.1!×!10U20!C! 2685! T! !! !! !! !! 1.8!×!10U7!G! 2733! T! !! !! !! !! 5.5!×!10U3!
Table&3.3.&Predominant&ORF256&haplotypes&within&late&day&virus&samples&&aThe%nucleotide%(NT)%position%is%based%on%the%ORF286%region,%with%the%first%nucleotide%of%the%GP2%start%site%as%the%first%position.%The%amino%acid%(AA)%denotes%the%associated%protein%and%amino%acid%at%the%NT%position.%If%an%NT%change%occurs%in%an%overlapping%reading%frame,%the%associated%amino%acid%is%listed%for%both%proteins.%%bHaplotypes%A%and%B%represent%the%haplotypes%present%at%the%highest%and%second%highest%frequencies%within%each%pig,%respectively.%Haplotypes%include%both%sites%that%vary%between%haplotypes%and%shared%consensus%changes%from%the%inoculum.%T%cThe%consensus%nucleotide%and%amino%acid%in%the%inoculum.%%*%%Synonymous%change%+%%Significant%in%CMH%^%%Change%located%in%previously%identified%B8cell%epitope%%
% Position& Haplotype&A& &Haplotype&B& Inoculum&Pig% NT% AA% NT% AA% %%Inoc.% %%%%%%%%7%dpi% Hap%Freq.% NT% AA% %%Inoc.% %%%%%%%7%dpi% Hap%Freq.% NT% AA%
1113%
114% GP2% 38*% T% C% 100% 100%
35%
C% C% 0% 0%
31%
T% C%E% 37% F% L% F%291% GP2% 97% G% M% 56% 100% A% I% 44% 0% G% M%824% GP3% 67*% C% Y% 100% 100% T% Y% 0% 0% C% Y%878% GP3% 85*% G% E% 0% 0% A% E% 52% 100% A% E%896% GP3% 91*% G% G% 100% 100% A% G% 0% 0% G% G%909% GP3% 96^% T% S% 40% 56% C% P% 60% 44% C% P%1050+% GP3% 143% T% F% 48% 100% T% F% 48% 0% C% L%1282% GP3% 220% T% L% 100% 100% C% P% 0% 0% T% L%GP4% 38*% T% T% T%1553+% GP4% 129% G% V% 12% 44% G% V% 12% 44% A% I%1795% GP5% 27^% C% A% 96% 100% T% V% 4% 0% C% A%5a% 30*% C% C% C%
90%
Table&3.3&continued&
% Position& Haplotype&A& &Haplotype&B& Inoculum&Pig% NT% AA% NT% AA% %%Inoc.% %%%%%%%%%%7%dpi% Hap%Freq.% NT% AA% %%Inoc.% %%%%%%%%%%7%dpi% Hap%Freq.% NT% AA%
3197%
68% GP2% 23% G% S% 0% 0%
46%
A% N% 100% 100%
42%
A% N%134% GP2% 45^% T% V% 0% 10% T% V% 0% 10% C% A%E% 43*% G% G% G%711% GP2% 237% G% M% 4% 0% G% M% 4% 0% A% I%GP3% 30% A% A% T%1050+% GP3% 143% T% F% 48% 90% T% F% 48% 90% C% L%1426% GP4% 86*% A% T% 100% 100% G% T% 0% 0% A% T%1553+% GP4% 129% G% V% 12% 30% G% V% 12% 30% A% I%1795% GP5% 27^% C% A% 96% 100% T% V% 4% 0% C% A%5a% 30*% C% C% C%1810% GP5% 32^% G% S% 0% 0% A% K% 100% 100% A% N%5a% 35*% Q% Q% Q%1811% GP5% 32^% C% S% 100% 100% A% K% 0% 0% C% N%5a% 36% Q% K% Q%1838% GP5% 41*^% A% L% 0% 0% A% L% 0% 0% G% L%5a% 45% N% N% D%1884% GP5% 57% G% E% 0% 0% G% E% 0% 0% A% K%
3068%
20% GP2% 7% G% R% 4% 0%
100% N/A%
A% K%E% 5% Q% Q%1050+% GP3% 143% T% F% 48% 100% C% L%1523+% GP4% 119% A% S% 0% 22% G% G%1553+% GP4% 129% G% V% 12% 78% A% I%1795% GP5% 27^% T% V% 4% 0% C% A%5a% 30*% C% C%2489% M% 63% T% L% 0% 0% G% V%
91%
Table&3.3&continued&
&% % Position& Haplotype&A& &Haplotype&B& Inoculum&% NT% AA% NT% AA% %%Inoc.% %%%%%%%%7%dpi% Hap%Freq.% NT% AA% %%Inoc.% %%%%%%%%7%dpi% Hap%Freq.% NT% AA%
1134%
122% GP2% 41^% T% L% 100% 100%
46%
C% S% 0% 0%
39%
T% L%E% 39*% F% F% F%131% GP2% 44^% C% P% 0% 0% T% L% 100% 100% T% L%E% 42*% A% A% A%1050+% GP3% 143% T% F% 48% 100% T% F% 48% 100% C% L%1523+% GP4% 119% A% S% 0% 12% G% G% 100% 88% G% G%1553+% GP4% 129% G% V% 12% 100% G% V% 12% 100% A% I%2685% M% 128% A% N% 100% 100% A% N% 100% 100% A% N%
3161%
289% GP2% 97% G% V% 8% 11%
24%
G% V% 8% 11%
19%
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3197GA! ORF2G6! Yes! GP5;!possibly!GP2/3/4!3197GAG2G4! ORF2G4! No!3197GAG5! ORF5! Yes!B! 3197GB! ORF2G6! Yes! GP5!3197GBG2G4! ORF2G4! No!3197GBG5! ORF5! Yes!
1113! Rebound! A! 1113GA! ORF2G4*! Yes! GP2/3/4!B! 1113GB! ORF2G6! Yes! GP5!1113GBG2G4! ORF2G4! No!1113GBG5! ORF5! Yes!
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! !! IC50! CC50!
! !! μg/ml! μM! μg/ml! μM!
Compound! Max! Mean! 95%!CI! Mean! 95%!CI! Mean! 95%!CI! Mean! 95%!CI!
1! 100.0$ 5.91$ 4.66,$ 7.47$ 29.82$ 23.51,$37.69$ ND$$ $$ $$ $ $$ $$
2! 93.4$ 1.76$ 1.18,$ 2.42$ 14.90$ 9.99,$20.48$ 52.95$$ 45.84,$$ 61.79$$ 448.20$ 388.01,$$523.02$$
16! 97.2$ 1.87$ 1.20,$ 2.64$ 7.98$ 5.12,$11.27$ 91.78$$ 53.76,$$ 141.50$$ 391.80$ 229.50,$$604.06$$
13! 99.8$ 1.74$ 1.33,$ 2.21$ 7.24$ 5.54,$ 9.20$ 75.98$$ 58.07,$$ 101.60$$ 316.24$ 241.70,$$422.88$$
17! 99.2$ 1.56$ 1.42,$ 1.72$ 5.95$ 5.41,$ 6.56$ 79.02$$ 68.21,$$ 92.08$$ 301.25$ 260.04,$$351.04$$
19! 100.0$ 1.68$ 1.27,$ 2.14$ 4.82$ 3.64,$ 6.14$ 37.59$$ 28.80$$ 55.34$$ 107.88$ 82.65,$$158.82$$
18! 100.0$ 1.18$ 1.09,$ 1.26$ 4.47$ 4.12,$ 4.77$ ND$$ $$ $$ $ $$ $$
23! 99.1$ 1.10$ 0.62,$ 1.58$ 4.19$ 2.36,$ 6.02$ 89.37$$ 74.96,$$ 107.40$$ 340.70$ 285.77,$$409.44$$





























Compound! 102! 103! 104! 105! p@value!
1! 100.00$ ±0.00$ 100.00$ ±0.00$ 99.99$ ±0.01$ 100.00$ 0.00$ 0.07$
19! 99.96$ ±0.14$ 99.94$ ±0.00$ 99.93$ ±0.01$ 99.93$ 0.01$ 0.85$
13! 99.28$ ±0.66$ 99.35$ ±0.10$ 99.04$ ±0.31$ 98.75$ 0.15$ 0.21$
23! 98.00$ ±2.83$ 97.98$ ±0.71$ 97.56$ ±0.99$ 97.86$ 0.69$ 0.66$
18! 98.46$ ±2.18$ 98.06$ ±0.31$ 97.43$ ±0.28$ 98.86$ 0.00$ 0.65$
17! 97.69$ ±1.09$ 97.95$ ±2.38$ 98.76$ ±1.28$ 99.62$ 0.00$ 0.63$
16! 97.00$ ±1.15$ 95.69$ ±2.39$ 95.66$ ±1.60$ 96.04$ 0.53$ 0.67$





group with TBSCl, PCC oxidation of the remaining alcohol followed by dibromonation, 













































Scheme 2. Total synthesis of 1-(E)-atractylodinol. 
 
 We started the synthesis from 3-(2-furyl)acrolein 4, as shown in Scheme 2. We 
chose to utilize Corey-Fuchs reaction to obtain the termianl alkyne from the aldehyde in 
two steps. Treatment of 4 with carbon tetrabromide and tripehnylphosphine gave us 




(carbethoxymethylene)-triphenylphosphorane 14 converted propargyl alcohol to 
compound 23 in one pot, the E isomer was isolated in 30% yield after flash column 
chromatography purification. Copper catalyzed Cadiot–Chodkiewicz coupling reaction 
was used to build C-C bond between iodoalkyne 11 and acetylene 12. Unfortunately, the 
reaction did not go through as expected, ester analog 13 was not harvested after reaction 
and only the starting materials were recycled after the workup. 
 






















Scheme 4. Alternate synthetic route of 13. 
 
 Due to the faliture of the original plan at the final stage, a new route was required 
to continue our project. We did not want to start from the beginning, so enyne 2 was kept 
in the alternate plan. Instead of a coupling reaction between furyl iodoalkyne 11 and ester 
12, iodoalkyne 15 and enyne 2 were carried on to the coupling reaction. The compound 
was made from terminal alkyne 12 with morpholine hydroiodide salt 10, followed the 
same procedure discribed before. The conversion yield was 99%, suprisingly high, 
compared to 66% yield for compound 11. The same copper catalyzed coupling condition 



































Scheme 5. Synthesis of dimers 16, 17, 18 and 19. 
 
 Since dimer 16 showed good antiviral activity, our thought was to change the 
solubility of future analogs based on the structure of 16. The in vitro test was performed 
in serum, in which the major component was water solution, we hoped that the better 
solubility in polar sovents would increase the antiviral property of our compounds. To 
improve the solubitity of analogs in water, we focused on installing polar functional 
groups, such as carbonyl groups, hydroxy groups and amino groups, on to the dimer 16, a 




decompose and much more stable to store at room temperature, . The salt form also has 
better solubility compared to orgnic compound 19 when added into food as drug to feed 
animals. So far, we have successfully designed a scalable route to synthesize an effecive 





















Scheme 6. Synthesis of 23. 
 
 With the success of antiviral drug 19, we continued to design more analogs. 
Another idea was to put two aldehyde groups on the molecule, the attempt is shown in 
Scheme 6. Firstly, we tried to get dimer 23 from 5-methyl furfural 20. Addition of freshly 
made propargylmagnesium bromide at -78 °C converted 20 into seconary alcohol 21 in 
70% yield. Protection of alcohol with MsCl, followed by elimiation with triethylamine 
yielded enyne 22 in 53% yield as the mixture of cis and trans isomers. The previously 
used coupling condition was applied again to produce dimer 23 in 52% yield. The 
coupling yield was higher than previous applications, maybe due to the electron donating 









compound 26 and 27 were 56% and 11%, respectively, which indicated that neither of 
these two compounds would be effective to eliminate PRRSV. Moreover, the low PVN 
values also revealed that the stable benzene ring would not increase the effectiveness of 
analogs and the furan rings were one of the most crucial components for the antiviral 










































Scheme 8. Synthesis of 26 and 27. 
 
 Among all the privious synthesized molecules, we also found out that small 
simple molecules 2 and 12 showed anti-PRRSV activity. The PVN value of compound 2 
was 93.4% and 95.6% for compound 13. So we changed our focus on same small simple 
molecules which could be synthesized in less than four steps, and hoped that we could 
find a much more cost-efficient molecule inhibitor for PRRSV. The compounds we made 
E"
16 
are ester 28, 29 and 30, beisdes secondary alcohol 21 which was an intermediate for 



















28 29 30  
Scheme 9. Other small molesules for biology test. 
 
 The synthetic methods towards compound 29 and 30 are exhibted in Scheme 10. 
The Pd and Cu catalyzed Sonogashira coupling reaction was performed between terminal 
alkyne 2 and aryl bromide 31 to build a carbon-carbon bond to yield ester 29 in 31% 
yield. For compound 30, we started from furfural 32, followed by the treatment of CBr4 
and PPh3. Then the dibromo compound 33 was converted to bromo compound 34, which 
was a mixture of cis and trans isomers, with dimethyl phosphite (MeO)2POH and triethyl 
amine in DMF.27 However, unlike compounds 2 and 12, the new synthesized products 21, 
29 and 30 all had poor antiviral activity with PVN value below 65%. In addition, the 
most interesting result was that the PVN value of compound 28 was -24%, the only 
negative value among all the compounds. It means that compound 28 stimulated the 
replication of PRRSV, instead of killing the virus. At this point, none of our attempts to 
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